GSPQX
Price
$20.44
Change
+$0.07 (+0.34%)
Updated
Aug 21 closing price
Net Assets
3.94B
KNGAX
Price
$11.78
Change
+$0.06 (+0.51%)
Updated
Aug 21 closing price
Net Assets
48.67M
Interact to see
Advertisement

GSPQX vs KNGAX

GSPQX vs KNGAX Comparison Chart in %
View a ticker or compare two or three
VS
GSPQX vs. KNGAX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSPQX is a StrongBuy and KNGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSPQX has more cash in the bank: 3.94B vs. KNGAX (48.7M). KNGAX pays higher dividends than GSPQX: KNGAX (1.34) vs GSPQX (0.06). GSPQX was incepted earlier than KNGAX: GSPQX (21 years) vs KNGAX (9 years). GSPQX (1.86) and KNGAX (1.82) have similar cost to investors . KNGAX is a more actively managed with annual turnover of: 422.70 vs. GSPQX (29.00). GSPQX (1000) and KNGAX (1000) have matching initial minimum investment requirements. GSPQX annual gain was more profitable for investors over the last year : 13.89 vs. KNGAX (1.39). GSPQX return over 5 years is better than : 27.70 vs. KNGAX (-10.01).
GSPQXKNGAXGSPQX / KNGAX
Total Expense Ratio1.751.20146%
Annual Report Gross Expense Ratio1.861.82102%
Fund Existence21 years9 years-
Gain YTD12.6513.107407%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B48.7M8,086%
Annual Yield % from dividends0.061.345%
Returns for 1 year13.891.391,002%
Returns for 3 years39.77-4.68-849%
Returns for 5 years27.70-10.01-277%
Returns for 10 years75.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USIO2.810.15
+5.64%
Usio
PRLD6.630.13
+2.00%
Prelude Therapeutics
PMAX1.260.02
+1.61%
Powell Max Limited
BWXT156.780.34
+0.22%
BWX Technologies
SUPN45.85-1.60
-3.37%
Supernus Pharmaceuticals